MPE launches a report focused on the impact of AL amyloidosis in quality of lifeAL amyloidosis, MPE21 November 2023
ESMO 2023 | Patient Advocacy Track highlights challenges in access, caregiver support and digitalisationConferences, MPE27 October 2023
MPE to present at European Society for Medical Oncology (ESMO) Annual Congress 2023Conferences, MPE17 October 2023
EMA CHMP gives positive recommendation to elranatamab for the treatment of relapsed or refractory myelomaAccess, MPE, Myeloma13 October 2023
Watch the recording of the EHA 2023 highlights webinarAL amyloidosis, MPE, Myeloma, Videos10 July 2023
Sign up for the MPE webinar on EHA myeloma and AL amyloidosis highlights AL amyloidosis, Conferences, MPE, Myeloma14 June 2023
